Clinical trial · Interventional
Prospective Cohort Study With Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma
Prospective Cohort Study With Risk-adapted Central Nervous System Evaluation in Diffuse Large B-cell Lymphoma
NCT01202448CI-TRIAL-00016967PROCESScompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is to evaluate the incidence of central nervous system (CNS) relapse or metastasis in patients with diffuse large B-cell lymphoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Diffuse Large B-cell Lymphoma | Diffuse Large B-Cell Lymphoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| CSF analysis | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- ACTIVE_COMPARATOR
- label
- DLBCL with risk factor
- description
- Patients have any of risk factors for secondary CNS involvement
- interventionNames
- Procedure: CSF analysis
Primary outcomes (1)
- measure
- CNS relapse/involvement
- timeFrame
- Up to 2 years after participants are enrolled.
- description
- After enrollment, patients will be monitored to check the CNS relapse or involvement
Secondary outcomes (1)
- measure
- survival
- timeFrame
- Up to 2 years after participants are enrolled
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: 1. Newly diagnosed patients with diffuse large B cell lymphoma 2. \> 20 years 3. life expectancy more than 6 months 4. Written informed consent Exclusion Criteria: 1. Refusal to informed consent 2. Lymphomas other than diffuse large B cell lymphoma 3. Primary CNS lymphoma
References
Publications (0)
Data not yet available
No reference posted for this study.